Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse - Test2 - elhamkhani - TriplyDB

Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse

Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse

http://www.wikidata.org/entity/Q35345762

about

Molecular diagnostics of neurodegenerative disorders Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease Epigenetic mechanisms of neurodegeneration in Huntington's disease Placental DNA Methylation Related to Both Infant Toenail Mercury and Adverse Neurobehavioral Outcomes A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests Age-associated chromatin relaxation is enhanced in Huntington's disease mice.Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets.Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich's Ataxia.Chromatin plasticity and the pathogenesis of Huntington disease.Skp2-macroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis.A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.Epigenetic mechanisms in neurological disease Rho Kinase Pathway Alterations in the Brain and Leukocytes in Huntington's Disease.HTRF analysis of soluble huntingtin in PHAROS PBMCs.Transcriptome study of differential expression in schizophrenia.Biomarkers for Huntington's disease: an update.Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities.Epigenetics components of aging in the central nervous system.Neuroprotective effects of psychotropic drugs in Huntington's disease Prospects for neuroprotective therapies in prodromal Huntington's disease.Histone variants: key players of chromatin.Potential therapeutic targets in polyglutamine-mediated diseases.Challenges of Huntington's disease and quest for therapeutic biomarkers.HDNetDB: A Molecular Interaction Database for Network-Oriented Investigations into Huntington's Disease.Huntington's Disease: Calcium Dyshomeostasis and Pathology Models Metal ions modulate the conformation and stability of a G-quadruplex with or without a small-molecule ligand.The challenge in translating basic research discoveries to treatment of Huntington disease.Age-related epigenetic regulation in the brain and its role in neuronal diseases Does chromatin modulation provide the first wet biomarker for Huntington's disease?Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.Age-associated bimodal transcriptional drift reduces intergenic disparities in transcription.

P2860

Q26786821-BA1EEF38-27A0-4C66-BD96-435336281AF0 Q27022757-097E1780-EEF5-4931-832A-ABF510F27E2C Q28297936-8630D869-F9E7-4219-9ED7-CA87CDD9C2AF Q28397750-8002F692-7DEE-4672-ABB0-2AD1BD5C6F18 Q28535325-30F1134D-1933-403E-BC5A-ECF9CA63F035 Q33563614-ED8AA6F8-101D-4F56-972F-D1AEE4DEAF74 Q34431341-AAA40202-86BD-48FD-961D-AC9F64B1C77B Q35024695-398A944A-DA0A-45A6-B312-61E377037CE1 Q35049600-8CB7FAD2-D7DA-4263-92E9-85C302B05592 Q35149824-798D0C94-27CE-41FF-A404-3251D81498D0 Q35345134-D6B5BAB1-27BC-4C56-9586-C673870A3FAE Q35845610-A30EB4B1-051D-4BA1-B2D5-5B09244E86FE Q35976721-9DD94883-DB1C-4C66-ACEA-D612A40C5305 Q36090810-D28B3240-A70A-44CD-951E-C88C724B99A3 Q36116666-E9ECD485-4485-4C52-BE31-E801279C4DE3 Q36469923-992DAD1F-F656-42CD-8CC5-58221DFFC9B1 Q36682567-33C50CF4-B741-4859-A128-657A2F16B3D4 Q36772887-4535511E-F7C5-435B-B93E-7D8178B61107 Q37227046-004E8F9E-495E-4574-BE5F-37B88A4ED72D Q37332227-FBCACE84-7CDA-44F4-B47E-B2361DF7DE1D Q38088407-5C89E561-345D-4C7C-B212-C9A5DA32D3E0 Q38094663-634239C0-1045-4544-BB39-B7B7424684C3 Q38153255-83CF99FE-260B-4741-9B81-E9AFDA15FBF6 Q38163877-2E794EA9-9D1F-4424-BDD1-2B7CC16AE850 Q38191477-6EE07A92-2117-4123-9594-C5CD7B8AC832 Q38208178-713BDA24-50D7-46C8-86FE-45164C3BDD2B Q38246221-C27F5418-0D93-4530-9159-102726B9C2F3 Q38257697-49D0892C-DC7B-4BC7-AC2E-B019F13533C8 Q38681978-94568A42-666F-403E-9FA7-94D522239887 Q39456024-EFD29D8A-2A80-4218-9434-F2FF21324A67 Q40527829-1075CC79-74D9-4A58-A524-676ED65793B5 Q41967848-4EEF6324-4C72-466F-9FB2-DE7EF3A46331 Q42317072-F53E745C-F2D8-4DB3-8CA6-F8B5AF339E2F Q45288713-2C4C7FE1-8DF0-46AE-9D58-52A05CC57829 Q47138180-F984EED1-425E-4EDF-8BFD-7E677083078D Q53070588-228150CD-1003-4D76-9BF0-C10D73DFE396

P2860

Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse

http://www.wikidata.org/entity/Q35345762

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Transcriptional modulator H2A ...... ease activity in man and mouse

@ast

Transcriptional modulator H2A ...... ease activity in man and mouse

@en

type

label

Transcriptional modulator H2A ...... ease activity in man and mouse

@ast

Transcriptional modulator H2A ...... ease activity in man and mouse

@en

prefLabel

Transcriptional modulator H2A ...... ease activity in man and mouse

@ast

Transcriptional modulator H2A ...... ease activity in man and mouse

@en

P1433

Q35345762-CB0169B9-E76B-4329-9DB3-0F29F6F6ED4F

P1476

Q35345762-1097652E-066A-418F-BD82-2B8B9BB9C298

P2093

Q35345762-352C0087-CFAD-4AD8-9F76-9081F6080AC3

Q35345762-40CF5206-6FDD-4E83-A491-CC8995876921

Q35345762-4E0E46C9-A283-42F3-8FA3-99892FE32464

Q35345762-5A01F309-FC3A-4568-AEC1-81465C50DA05

Q35345762-619B617B-2D5F-4670-84EF-987FA0B843F5

Q35345762-7631D5DD-EDC1-4F29-9954-7C1740B4AF42

Q35345762-7F7ECC2B-D11E-4B2C-B50B-E2D1C3A4F6CA

Q35345762-8ECCA7A1-A8C1-4D47-A9ED-5A2BDC9AF06C

Q35345762-A5877CA7-A297-4AA3-95AD-85680D7CFFB7

Q35345762-BFBC3EB1-C0D5-46BE-8984-6FEA51589CE9

P2860

Q35345762-038CBABB-D09F-4189-B1C5-0575B7A84FA4

Q35345762-041E92F4-BB8B-4D05-A727-E4A7D17954A7

Q35345762-07779B98-676A-49C9-961D-0C4D688BCCE0

Q35345762-08E964A0-0C92-4F78-AF9B-B8555EF9CCBA

Q35345762-0A600537-F372-4D2E-AD65-DB86EBB82541

Q35345762-1174124C-CC4F-4C05-8551-7B977C021B7D

Q35345762-23C16344-E067-4356-8E8C-7974021481D0

Q35345762-2C10092F-1811-497D-B7A8-6E36743DFFC9

Q35345762-400C7192-23C8-40B3-BF38-968A43DEDCA4

Q35345762-491DA8E1-6BAA-4287-BC0A-195F35E44CA2

P304

Q35345762-366DEB25-3D8D-4B9C-BA21-A808260DB463

P31

Q35345762-20C481D5-8AB6-4AAC-B636-C97559696E60

P356

Q35345762-6A0B1DFC-D555-473C-8800-654179D0A57B

P407

Q35345762-87434848-E6F4-4544-9769-7B8E953CE115

P433

Q35345762-3448C503-1540-47CC-AA80-B85B3B2BDCA6

P478

Q35345762-543A6778-BAAB-443D-BF25-9B180C5D5871

P50

Q35345762-75D78FC8-D0FA-4078-9043-804FD12F626E

Q35345762-8E21998D-15CE-46E5-A9C3-2092BE3ADBD7

P577

Q35345762-391C09B4-A7FA-4B67-BDDA-08169EE4FA3A

P5875

Q35345762-6914F742-C711-4C09-BAD9-6AB44243796D

P698

Q35345762-23D12FFB-448B-42C9-9D0F-4B9DFE287C1B

P921

Q35345762-2BB6552A-5ACA-4F2F-B9FE-BA0A899211AE

P932

Q35345762-372EC930-C4BB-4DF6-A5C0-5A37F17E3F4B

P356

PNAS.1104409108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Transcriptional modulator H2A ...... ease activity in man and mouse

@en

P2093

Bin Zheng

http://www.w3.org/2001/XMLSchema#string

Clemens R Scherzer

http://www.w3.org/2001/XMLSchema#string

H Diana Rosas

http://www.w3.org/2001/XMLSchema#string

Hongliu Ding

http://www.w3.org/2001/XMLSchema#string

Joseph J Locascio

http://www.w3.org/2001/XMLSchema#string

Raman Chopra

http://www.w3.org/2001/XMLSchema#string

Vanita Chopra

http://www.w3.org/2001/XMLSchema#string

Wayne R Matson

http://www.w3.org/2001/XMLSchema#string

Yi Hu

http://www.w3.org/2001/XMLSchema#string

Zhixiang Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular markers of early Parkinson's disease based on gene expression in blood

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

Significance analysis of microarrays applied to the ionizing radiation response

A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation

Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease

The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling

Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy

Loss of apolipoprotein E receptor LR11 in Alzheimer disease

Neurological abnormalities in a knock-in mouse model of Huntington's disease

P304

17141-17146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1104409108

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Ferrante

Steven M Hersch

P577

2011-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51691238

http://www.w3.org/2001/XMLSchema#string

P698

21969577

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3193232

http://www.w3.org/2001/XMLSchema#string